Skip to main content

Published locations for Unresectable HCC: Suboptimal response to lenvatinib plus pembrolizumab beyond the first-line setting

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Unresectable HCC: Suboptimal response to lenvatinib plus pembrolizumab beyond the first-line setting

User login

  • Reset your password
  • /content/unresectable-hcc-suboptimal-response-lenvatinib-plus-pembrolizumab-beyond-first-line-setting
  • /fedprac/article/254134/hepatocellular-carcinoma/unresectable-hcc-suboptimal-response-lenvatinib-plus